Jean-Luc Pouly
Research Subjects
Jean-Luc Pouly has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
A. Audebert
1 shared publicationA. Crowe
1 shared publication- Anne-Sophie Gremeau
CHU Clermont-Ferrand, ART Department "AMP, CECOS", Clermont-Ferrand, France
1 shared publication - Antoine Torre
Division of Child Health, Obstetrics & Gynaecology, University of Nottingham, Maternity building of the City Hospital, Hucknall Road, NG5 1PB Nottingham, Royaume-Uni; Service de gynécologie-obstétrique, CHU de Rouen, Université de Rouen, Rouen, France
1 shared publication - Arnaud Fauconnier
Department of Gynecology & Obstetrics, Intercommunal Hospital Center of Poissy-Saint-Germain-en-Laye, Research Unit 7285 "Clinical Risks and Safety in Women's Health and Perinatal Health", Université Paris-Saclay, F-78300 Poissy, France
1 shared publication - Arnaud Wattiez
Latifa Hospital, Dubai P.O. Box 1853, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 25 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (17) , 3810
Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process
International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification—in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
- 25 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (17) , 3810
Open AccessOocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process
International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification—in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
- 1 July 2012
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 40 (7-8) , 419-428
Adhérences postopératoires et leur prévention en chirurgie gynécologique : II. Comment les prévenir ?
- 1 July 2012
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 40 (7-8) , 419-428
Adhérences postopératoires et leur prévention en chirurgie gynécologique : II. Comment les prévenir ?